From owner-biophys@hgmp.mrc.ac.uk  Tue Jul 17 15:23:20 2001
Return-Path: <owner-biophys@hgmp.mrc.ac.uk>
Received: from localhost (localhost [127.0.0.1])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 0489C17B45
	for <biophys-outgoing>; Tue, 17 Jul 2001 15:23:15 +0100 (BST)
Received: from localhost (localhost [127.0.0.1])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 12AE117B4B
	for <biophys-list@hgmp.mrc.ac.uk>; Tue, 17 Jul 2001 15:22:55 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 58C8017B0D
	for <biophys-list@hgmp.mrc.ac.uk>; Tue, 17 Jul 2001 15:22:40 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id PAA23206
	for biophys-list@hgmp.mrc.ac.uk; Tue, 17 Jul 2001 15:16:34 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: Dominic-Luc Webb molmed <domweb@mbox.ki.se>
X-Newsgroups: bionet.biophysics
Subject: nuclear accumulation, but how?
Date: Tue, 17 Jul 2001 16:16:18 +0200
Organization: Stockholm University
Lines: 10
Message-ID: <Pine.GSO.4.33.0107171613070.8696-100000@mbox.ki.se>
Mime-Version: 1.0
Content-Type: TEXT/PLAIN; charset=US-ASCII
X-Complaints-To: abuse@su.se
To: biophys@hgmp.mrc.ac.uk
Sender: owner-biophys@hgmp.mrc.ac.uk
Precedence: bulk


Does anyone know if nuclear accumulation of glycolytic
intermediates has ever been described in mammalian
cells? Along the same line, has anyone described
mechanism by which oligonucleotides (charged),
introduced into the cytosol, enter the nucleus?


Dominic


.